Benefit-risk of rivaroxaban for extended thromboprophylaxis after hospitalization for medical illness: Pooled analysis from MAGELLAN and MARINER

Gary E. Raskob, Alex C. Spyropoulos, Theodore E. Spiro, Wentao Lu, Zhong Yuan, Bennett Levitan, Eunyoung Suh

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Benefit-risk of rivaroxaban for extended thromboprophylaxis after hospitalization for medical illness: Pooled analysis from MAGELLAN and MARINER'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science